microRNA regulation of mammalian target of rapamycin expression and activity controls estrogen receptor function and RAD001 sensitivity

[31] Viollet B(2010)FoxOs inhibit mTORC1 and activate Akt by inducing the expression of Sestrin3 and Rictor Developmental cell 18 592-17

[32] Guan KL(2004)Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton Current biology : CB 14 1296-693

[33] Sengupta S(2009)New hypotheses and opportunities in endocrine therapy: amplification of oestrogen-induced apoptosis Breast 18 S10-1097

[34] Peterson TR(2009)MicroRNA-18a prevents estrogen receptor-alpha expression, promoting proliferation of hepatocellular carcinoma cells Gastroenterology 136 683-31086

[35] Sabatini DM(2011)MicroRNA-221/222 confers breast cancer fulvestrant resistance by regulating multiple signaling pathways Oncogene 30 1082-211

[36] Huang J(2008)MicroRNA-221/222 negatively regulates estrogen receptor alpha and is associated with tamoxifen resistance in breast cancer The Journal of biological chemistry 283 31079-3127

[37] Manning BD(2013)17beta-estradiol up-regulates miR-155 expression and reduces TP53INP1 expression in MCF-7 breast cancer cells Molecular and cellular biochemistry 379 201-17879

[38] Huang J(2010)MicroRNA-155 functions as an OncomiR in breast cancer by targeting the suppressor of cytokine signaling 1 gene Cancer research 70 3119-593

[39] Dibble CC(2010)MicroRNA-155 regulates cell survival, growth, and chemosensitivity by targeting FOXO3a in breast cancer The Journal of biological chemistry 285 17869-79

[40] Matsuzaki M(2010)Correlation and quantitation of microRNA aberrant expression in tissues and sera from patients with breast tumor Gynecologic oncology 119 586-7164

[31] Viollet B(2010)FoxOs inhibit mTORC1 and activate Akt by inducing the expression of Sestrin3 and Rictor Developmental cell 18 592-17

[32] Guan KL(2004)Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton Current biology : CB 14 1296-693

[33] Sengupta S(2009)New hypotheses and opportunities in endocrine therapy: amplification of oestrogen-induced apoptosis Breast 18 S10-1097

[34] Peterson TR(2009)MicroRNA-18a prevents estrogen receptor-alpha expression, promoting proliferation of hepatocellular carcinoma cells Gastroenterology 136 683-31086

[35] Sabatini DM(2011)MicroRNA-221/222 confers breast cancer fulvestrant resistance by regulating multiple signaling pathways Oncogene 30 1082-211

[36] Huang J(2008)MicroRNA-221/222 negatively regulates estrogen receptor alpha and is associated with tamoxifen resistance in breast cancer The Journal of biological chemistry 283 31079-3127

[37] Manning BD(2013)17beta-estradiol up-regulates miR-155 expression and reduces TP53INP1 expression in MCF-7 breast cancer cells Molecular and cellular biochemistry 379 201-17879

[38] Huang J(2010)MicroRNA-155 functions as an OncomiR in breast cancer by targeting the suppressor of cytokine signaling 1 gene Cancer research 70 3119-593

[39] Dibble CC(2010)MicroRNA-155 regulates cell survival, growth, and chemosensitivity by targeting FOXO3a in breast cancer The Journal of biological chemistry 285 17869-79

[40] Matsuzaki M(2010)Correlation and quantitation of microRNA aberrant expression in tissues and sera from patients with breast tumor Gynecologic oncology 119 586-7164